相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combining molecular targeted therapies: clinical experience
Xavier Pivot et al.
ANTI-CANCER DRUGS (2011)
A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies
Gabriele Schaefer et al.
CANCER CELL (2011)
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and New Therapeutic Perspectives in Non Small Cell Lung Cancer
Laura Bonanno et al.
CURRENT DRUG TARGETS (2011)
Bispecific digoxigenin-binding antibodies for targeted payload delivery
Silke Metz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy
Diane Seimetz et al.
CANCER TREATMENT REVIEWS (2010)
Safety profile of new anticancer drugs
Laura Mansi et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases
Zhiqiang An
PROTEIN & CELL (2010)
Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
J. Veeken et al.
CURRENT CANCER DRUG TARGETS (2009)
Antibodies for Therapeutic Uses and the Evolution of Biotechniques
P. Nieri et al.
CURRENT MEDICINAL CHEMISTRY (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors
Michalis V. Karamouzis et al.
LANCET ONCOLOGY (2009)
Bispecific antibodies for cancer therapy The light at the end of the tunnel?
Patrick Chames et al.
MABS (2009)
The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases
Vinochani Pillay et al.
NEOPLASIA (2009)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Antibody engineering and modification technologies
David Filpula
BIOMOLECULAR ENGINEERING (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Kinomics: Characterizing the therapeutically validated kinase space
M Vieth et al.
DRUG DISCOVERY TODAY (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
